Rapid identification of mutations in a multidrug efflux pump in Pseudomonas aeruginosa

APMIS

Volumn 107, Issue 12, 1999, Pages 1109-1116

  Jalal, Shah ^a   Wretlind, Gunnar ^a   Gotoh, Naomasa ^b   Wretlind, Bengt ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Antibiotic resistance; Multidrug efflux pump; NIRCA; PCR

Indexed keywords

BACTERIAL DNA; BACTERIAL RNA; CHLORAMPHENICOL; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; GENETIC TRANSCRIPTION; IMMUNOBLOTTING; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

PSEUDOMONAS AERUGINOSA;

EID: 0033384416     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1999.tb01516.x     Document Type: Article

References (21)

1. 1. Jalal S, Wretlind B. Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa. Microb Drug Resist 1998;4:257-61.
2. 2. Martinez JL, Alonso A, Gomez-Gomez JM, Baquero F. Quinolone resistance by mutations in chromosomal gyrase genes. Just the tip of the iceberg? J Antimicrob Chemother 1998;42:683-8.
3. 3. Fukuda H, Hosaka M, Iyobe S, Gotoh N, Nishino T, Hirai K. nfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1995;39:790-2.
4. 4. Gotoh N, Tsujimoto H, Nomura A, Okamoto K, Tsuda M, Nishino T. Functional replacement of OprJ by OprM in the MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa. FEMS Microbiol Lett 1998;165:21-7.
5. 5. Gotoh N, Tsujimoto H, Tsuda M, Okamoto K, Nomura A, Wada T, Nakahashi M, Nishino T. Characterization of the MexC-MexD-OprJ multidrug efflux system in DeltamexA-mexB-oprM mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1998;42:1938-43.
6. 6. Hosaka M, Gotoh N, Nishino T. Purification of a 54-kilodalton protein (OprJ) produced in NfxB mutants of Pseudomonas aeruginosa and production of a monoclonal antibody specific to OprJ. Antimicrob Agents Chemother 1995;39:1731-5.
7. 7. Kohler T, Michea-Hamzehpour M, Henze U, Gotoh N, Curty LK, Pechere JC. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol 1997;23:345-54.
8. 8. Li XZ, Nikaido H, Poole K. Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1995; 39:1948-53.
9. 9. Masuda N, Gotoh N, Ohya S, Nishino T. Quantitative correlation between susceptibility and OprJ production in NfxB mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1996;40:909-13.
10. 10. Poole K, Gotoh N, Tsujimoto H, Zhao Q, Wada A, Yamasaki T, Neshat S, Yamagishi J, Li XZ, Nishino T. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol Microbiol 1996;21:713-24.
11. 11. Poole K, Krebes K, McNally C, Neshat S. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol 1993;175:7363-72.
12. 12. Poole K, Tetro K, Zhao Q, Neshat S, Heinrichs DE, Bianco N. Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression. Antimicrob Agents Chemother 1996; 40:2021-8.
13. 13. Srikumar R, Kon T, Gotoh N, Poole K. Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain. Antimicrob Agents Chemother 1998;42: 65-71.
14. 14. Wong KK, Poole K, Gotoh N, Hancock RE. Influence of OprM expression on multiple antibiotic resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1997;41:2009-12.
15. 15. Goldrick MM, Kimball GR, Liu Q, Martin LA, Sommer SS, Tseng JY: NTRCA. A rapid robust method for screening for unknown point mutations. Biotechniques 1996;21:106-12.
16. 16. Haseyama K, Kudoh T, Yoto Y, Suzuki NA, Chiba S. Analysis of genetic diversity in the VP1 unique region gene of human parvovirus B19 using the mismatch detection method and direct nucleotide sequencing. J Med Virol 1998;56:205-9.
17. 17. Wretlind B, Pavlovskis OR. Genetic mapping and characterization of Pseudomonas aeruginosa mutants defective in the formation of extracellular proteins. J Bacteriol 1984;158:801-8.
18. 18. Pitcher D, Saunders Na, Owen R. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett Appl Microbiol 1989;8:151-6.
19. 19. Heisig P. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother 1996;40:879-85.
20. 20. Kureishi A, Bryan LE. Pre-boiling high GC content, mixed primers with 3' complementation allows the successful PCR amplification of Pseudomonas aeruginosa DNA. Nucleic Acids Res 1992; 20:1155.
21. 21. Kureishi A, Diver JM, Beckthold B, Schollaardt T, Bryan LE. Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates. Antimicrob Agents Chemother 1994;38:1944-52.